Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Alison Walker selected to receive ASH-AMFDP Award

Alison Walker selected to receive ASH-AMFDP Award

IBS patients are at no greater risk of having polyps, colon cancer than healthy people undergoing colonoscopies

IBS patients are at no greater risk of having polyps, colon cancer than healthy people undergoing colonoscopies

False positives in screening tests

False positives in screening tests

Entelos, RegeneMed release iToxFX to screen novel compounds for potential toxicity issues

Entelos, RegeneMed release iToxFX to screen novel compounds for potential toxicity issues

'Anti-gluten pill' needed

'Anti-gluten pill' needed

Recipients for 2010 Scholar Awards announced

Recipients for 2010 Scholar Awards announced

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Critical follow-up evaluations provide opportunity to help physicians best evaluate their HF patients

Critical follow-up evaluations provide opportunity to help physicians best evaluate their HF patients

Colonoscopy screening recommended for people with family history of colon cancer

Colonoscopy screening recommended for people with family history of colon cancer

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

AMAG Pharmaceuticals reports fourth-quarter 2009 net product revenues of $12.8M attributable to Feraheme

AMAG Pharmaceuticals reports fourth-quarter 2009 net product revenues of $12.8M attributable to Feraheme

Determining personal risk for genetic disorders essential

Determining personal risk for genetic disorders essential

Precise immune disturbances leading to Coeliac disease: More insight

Precise immune disturbances leading to Coeliac disease: More insight

Unexplained, sudden anemia: Brown recluse spider bite

Unexplained, sudden anemia: Brown recluse spider bite

Midlothian Laboratories donates more than $3M worth of vitamins, nutritional supplements to AmeriCares

Midlothian Laboratories donates more than $3M worth of vitamins, nutritional supplements to AmeriCares

Shire receives marketing approval from FDA for VPRIV

Shire receives marketing approval from FDA for VPRIV

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Salmonella-infected mice help understand how symptoms of HLH develop

Salmonella-infected mice help understand how symptoms of HLH develop

PointCare Technologies donates rapid PointCare NOW tests to Haitian clinics

PointCare Technologies donates rapid PointCare NOW tests to Haitian clinics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.